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Abstract
Antimicrobial treatments result in the host’s enteric bacteria being exposed to the antimicro-
bials. Pharmacodynamic models can describe how this exposure affects the enteric bacte-
ria and their antimicrobial resistance. The models utilize measurements of bacterial
antimicrobial susceptibility traditionally obtained in vitro in aerobic conditions. However, in
vivo enteric bacteria are exposed to antimicrobials in anaerobic conditions of the lower
intestine. Some of enteric bacteria of food animals are potential foodborne pathogens, e.g.,
Gram-negative bacilli Escherichia coli and Salmonella enterica. These are facultative anaer-
obes; their physiology and growth rates change in anaerobic conditions. We hypothesized
that their antimicrobial susceptibility also changes, and evaluated differences in the suscep-
tibility in aerobic vs. anaerobic conditions of generic E. coli and Salmonella enterica of
diverse serovars isolated from cattle feces. Susceptibility of an isolate was evaluated as its
minimum inhibitory concentration (MIC) measured by E-Test1 following 24 hours of adapta-
tion to the conditions on Mueller-Hinton agar, and on a more complex tryptic soy agar with
5% sheep blood (BAP) media. We considered all major antimicrobial drug classes used in
the U.S. to treat cattle: β-lactams (specifically, ampicillin and ceftriaxone E-Test1), amino-
glycosides (gentamicin and kanamycin), fluoroquinolones (enrofloxacin), classical macro-
lides (erythromycin), azalides (azithromycin), sulfanomides (sulfamethoxazole/
trimethoprim), and tetracyclines (tetracycline). Statistical analyses were conducted for the
isolates (n30) interpreted as susceptible to the antimicrobials based on the clinical break-
point interpretation for human infection. Bacterial susceptibility to every antimicrobial tested
was statistically significantly different in anaerobic vs. aerobic conditions on both media,
except for no difference in susceptibility to ceftriaxone on BAP agar. A satellite experiment
suggested that during first days in anaerobic conditions the susceptibility changes with
time. The results demonstrate that assessing effects of antimicrobial treatments on
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resistance in the host’s enteric bacteria that are Gram negative facultative Anaerobe Bacilli
requires data on the bacterial antimicrobial susceptibility in the conditions resembling those
in the intestine.
Introduction
The spread of antimicrobial resistance (AMR) is reducing treatment options for bacterial infec-
tions in animals and man. A number of antimicrobial drug classes are used in both human and
veterinary medicines, e.g., β-lactams, aminoglycosides, fluoroquinolones, macrolides, sulfon-
amides, and tetracyclines [1]. In food animals such as beef cattle antimicrobial treatments are
used to sustain animal health and welfare [2]. The treatments, however, result in the exposure
of animal enteric bacteria to the drug or its active metabolites reaching the intestine. This may
promote AMR in the enteric bacteria. Some of animal enteric bacteria are potential foodborne
pathogens. Human food-borne infections with AMR bacterial strains are challenging to treat
[1,3]. Furthermore, the ingested AMR strains not causing disease can become a part of the
human enteric microbial community [4], and transfer genetic determinants of resistance to
other human bacteria [5]. Prevention of this potential food-borne risk requires mitigation of
AMR in enteric bacteria of food animals treated by antimicrobial drugs.
Pharmacodynamic models can be used to assess how antimicrobial drugs or their active
metabolites that reach the lower intestine of treated animals affect the enteric bacteria in the
anaerobic conditions of the intestine [6]. The models utilize measurements of bacterial suscep-
tibility to the antimicrobials, such as the minimum inhibitory concentration (MIC) of the
drugs [7–9]. Currently, the measurements obtained in vitro in aerobic conditions are utilized
[10]. However, potential foodborne pathogens among the animal enteric bacteria such as
Gram-negative bacilli Escherichia coli and Salmonella enterica are facultative anaerobes. Such
bacteria experience changes in physiology and population growth rates in anaerobic conditions
[11,12]. A number of bactericidal antimicrobial drug classes target growing-to-divide bacterial
cells [13–17] and therefore the bactericidal activity depends on the bacterial population growth
rates [18,19]. Other antimicrobial drug classes target bacterial functions that can be affected by
the physiological changes that facultative anaerobe bacteria experience in anaerobic conditions
[20–22]. Therefore, susceptibility of facultative anaerobe bacteria to different antimicrobial
drug classes likely changes between aerobic and anaerobic conditions. The objective of this
study was to investigate differences in the susceptibility, as measured by MIC, in aerobic vs.
anaerobic conditions of generic E. coli and Salmonella enterica of diverse serovars to major
antimicrobial drug classes: β-lactams, aminoglycosides, fluoroquinolones, classical macrolides,
azalides, sulfonamides, and tetracyclines. Bacterial isolates originally obtained from cattle feces
were used.
Materials and Methods
Bacterial isolates
Twenty five E. coli and 25 Salmonella enterica isolates were selected through systematic ran-
dom sampling from existing isolate collections at the Department of Diagnostic Medicine/
Pathobiology of Kansas State University. The isolates were obtained from cattle feces by earlier
field studies in the U.S. beef feedlots. All available generic E. coli isolates were included in one
sampling frame for the random selection of 25 isolates. A separate frame was implemented for
the random selection of isolates from the collection of each available serovar of Salmonella
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enterica so as to select a total of 25 isolates of diverse serovars. After the antimicrobial suscepti-
bility testing, all the isolates of E. coli and Salmonella which would be interpreted as susceptible
to the tested drug based on the clinical breakpoint interpretation for human infection [7] were
included in the statistical analyses (the isolates which would be interpreted as resistant were
excluded.) This design ensured that n30 isolates would be available for the statistical analysis
of the difference in the isolates’ susceptibility between the two conditions for each drug tested.
The analyzed set of isolates contained E. coli of serovars O26, O45, O103, O111, O145, and Sal-
monella enterica of serovars Agona, Anatum, Give, Infantis, Kentucky, Montevideo,
Muenchen, Oranienburg, and Typhimurium.
Antimicrobials
For each bacterial isolate, its MIC value in anaerobic conditions and its MIC value in aerobic
conditions were determined using E-Test1 as described below for the following drugs as repre-
sentatives of their antimicrobial classes: ampicillin for older β-lactams aminopenicillins and
ceftriaxone for newer β-lactams cephalosporins; gentamicin and kanamycin for aminoglyco-
sides; enrofloxacin for fluoroquinolones; erythromycin for classic macrolides; azithromycin for
azalides; sulfamethoxazole/trimethoprim for sulfonamides; and tetracycline for tetracyclines.
Testing antimicrobial susceptibility of bacterial isolates
The E-Test1 (bioMerieux, Durham, NC, USA) assay was chosen to test antimicrobial suscepti-
bility of the isolates for two reasons. Firstly, it is suitable for measuring MIC in both aerobic
and anaerobic conditions [23–27]. Secondly, the assay evaluates the exact MIC value on contin-
uous scale (rather than MIC ranges); this was particularly useful for comparing the MIC values
for individual isolates between the two conditions. Escherichia coli ATCC 25922 strain was
included in the experiments for each drug as a reference strain; the MIC for this strain in aero-
bic conditions was checked against the expected ranges, as per E-Test1manufacturer's
recommendations.
Each bacterial isolate used was purified at the time of original isolation and stored at -80°C.
From the thawed freezer tube, the isolate was plated using an inoculation loop on a plate of the
selected agar and incubated at 37°C for 24 hours. For the aerobic test, two to three colonies
were picked from the agar plate using an inoculation loop and suspended in 9 mL Mueller-
Hinton broth (MHB) (BD Diagnostic, Sparks, MD, USA) until the optical density of the sus-
pension was equivalent to a 0.5 McFarland turbidity standard. A sterile cotton swab applicator
was used to plate the suspension (approximately 100 μL, as per E-Test1manufacturer’s recom-
mendations) on a new plate of the selected agar. The E-Test1 strip containing the antimicro-
bial drug was placed in the center of this plate, and the plate was incubated upside down at
37°C for 24 hours, after which the result was read and recorded. For reading the result, an
ellipse-shaped zone of bacterial growth inhibition centered along the strip was evaluated visu-
ally; the MIC value was read as the drug concentration on the strip where the ellipse’s edge
intersected the strip, as per E-Test1manufacturer's recommendations. For the anaerobic test,
all these procedures were performed in an anaerobic chamber (Thermo Fisher Scientific Inc.,
Waltham, MA, USA); a sufficient number of colonies were picked up from the first agar plate
for the optical density of the suspension in MHB to be equivalent to a 0.5 McFarland turbidity
standard. With this experimental design, the bacterial culture was exposed to the aerobic or
anaerobic conditions for 24 hours (while on the first agar plate) prior to the test of its antimi-
crobial susceptibility, and for further 24 hours during the test (while on the second agar plate
with the test strip). The aerobic and anaerobic tests were performed separately on Mueller-
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Hinton (MH) agar (Becton, Dickinson and Company, Sparks, MD, USA) and on a more com-
plex tryptic soy agar with 5% sheep blood (BAP) agar (Remel, Lenexa, KS, USA).
A satellite experiment was performed to investigate how quickly from the start of bacterial
exposure to anaerobic conditions the physiological changes in the bacteria lead to a detectable
change in the bacterial susceptibility to antimicrobials. The experiment was conducted with
five isolates of E. coli and five isolates of Salmonella enterica selected at random from the iso-
lates in the study interpreted as susceptible to all antimicrobials tested based on the clinical
breakpoint interpretation for human infection [7]. The experiment was performed with the 10
isolates for ampicillin, gentamicin, kanamycin, and enrofloxacin, and with the five E. coli iso-
lates only for azithromycin. The experiment with a given antimicrobial drug was performed on
either MH or BAP agar. In the experiment, each of 10 isolates was plated in duplicate on two
plates of the selected agar and incubated at 37°C for 24 hours aerobically. From the first plate,
two to three colonies were picked to perform E-Test1 on a new plate aerobically. The second
plate was transferred to the anaerobic chamber, and two to three colonies were picked up from
the plate to perform E-Test1 anaerobically on a new plate. These tests provided measurements
of the isolate’s susceptibility to the antimicrobials in aerobic conditions, and in anaerobic con-
ditions following 0 hours of adaptation to these conditions. Each of the 10 isolates was also
freshly plated in the anaerobic chamber on a third agar plate. Following each 12 hours of incu-
bation in the chamber at 37°C, colonies were picked from this plate (sufficient number of colo-
nies for the optical density of the suspension in MHB to be equivalent to a 0.5 McFarland
turbidity standard) to perform E-Test1 anaerobically on a new plate. This provided measure-
ments of the isolate’s susceptibility to the antimicrobials in anaerobic conditions following a
12, 24, 36, and 48 hour period of adaptation to these conditions.
Statistical analysis
Statistical significance of the difference between the MIC values for the isolates in the anaerobic
and aerobic tests was evaluated for each bacterial species, antimicrobial drug tested, and agar
media combination. The statistical significance was evaluated using the t-test for paired sam-
ples assuming heteroscedasticity implemented in Microsoft Excel 20131 software for Windows
(Microsoft Corporation, Redmond, WA, USA); and using the nonparametric Wilcoxon
signed-rank test implemented in SigmaPlotTM v. 13.0 software (Systat Software Inc., San Jose,
CA, USA). Descriptive statistics of the distributions of the MIC values and differences between
the MIC values in the two conditions for the isolates were obtained in Microsoft Excel 20131
software. Potential correlation between the relative magnitude of the MIC values of individual
isolates in aerobic and anaerobic conditions across the isolates tested was evaluated using the
nonparametric Spearman correlation coefficient implemented in SigmaPlotTM v. 13.0 software.
Figures were prepared in SigmaPlotTM v. 13.0 software.
Results
Descriptive statistics of the MIC value distributions for the antimicrobial drugs tested in aero-
bic and anaerobic conditions for the E. coli and Salmonella enterica isolates included in the sta-
tistical analyses are given in Table 1. The isolates (n30) included in the analyses were those
that would be interpreted as susceptible to the antimicrobial drugs based on the MIC values in
the aerobic tests and the clinical breakpoint interpretation for human infection [7]. The
descriptive statistics of the differences between the MIC values in the anaerobic and aerobic
tests, and the results of tests of statistical significance of the differences are also included in
Table 1. The results are presented graphically in Fig 1.
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Susceptibility of E. coli and Salmonella enterica of diverse serovars (n30) isolated from cat-
tle feces to all antimicrobial drug classes considered was statistically significantly different in
anaerobic compared with aerobic conditions (Table 1, Fig 1). The direction of the difference in
susceptibility between the two conditions was similar for the two bacterial species for each anti-
microbial class. In particular, susceptibility to β-lactams such as aminopenicillins and third
generation cephalosporins, fluoroquinolones, sulfanomides, and tetracyclines increased signifi-
cantly in anaerobic compared with aerobic conditions, as was demonstrated by lower MIC val-
ues in anaerobic conditions (Fig 1 parts I, II, V, VIII, and IX). Susceptibility to
aminoglycosides, classic macrolides, and azalides decreased significantly in anaerobic com-
pared with aerobic conditions, as was demonstrated by higher MIC values in anaerobic condi-
tions (Fig 1 parts III, IV, VI, and VII).
The direction of the difference in susceptibility between aerobic and anaerobic conditions
for both bacterial species to every antimicrobial drug tested was consistent between MH and
Table 1. Descriptive statistics of the MIC distributions, and descriptive statistics and statistical significance of the differences between the MIC
values in anaerobic and aerobic conditions for antimicrobials tested (E-Test1 on Mueller-Hinton agar) for E. coli and Salmonella enterica of
diverse serovars.
Antimicrobial
drug class
Representative
drug used
Species Number
of
isolates
tested, n
MIC in
aerobic
tests,
median (1%,
99%
quartiles)
MIC in anaerobic
tests after a
24-hour
adaptation,
median (1%, 99%
quartiles)
Difference (MIC
anaerobic-MIC
aerobic),
median (1%,
99% quartiles)
Paired
t-test,
p-value
Wilcoxon
signed-rank
test, exact
p-value
Older β-lactams
aminopenicillins
Ampicillin E. coli 15 1.5 (1.1, 2.9) 0.75 (0.4, 1.5) -1.0 (-1.5, -0.04) <0.001 <0.001
Salmonella
enterica
19 0.7 (0.5, 1.9) 0.5 (0.4, 0.7) -0.25 (0, 1.4) <0.001 <0.001
Newer β-lactams
third generation
cephalosporins
Ceftriaxone E. coli 15 0.03 (0.02,
0.06)
0.02 (0.02, 0.03) -0.01 (-0.04,
0.00)
0.001 <0.001
Salmonella
enterica
19 0.05 (0.03,
0.09)
0.05 (0.02, 0.06) -0.02 (-0.07,
0.01)
0.002 <0.001
Aminoglycosides Gentamicin E. coli 20 0.75 (0.4,
2.0)
1.5 (1.0, 3.9) 1.0 (0.04, 3.1) 0.001 <0.001
Salmonella
enterica
22 0.5 (0.25, 1) 2.0 (0.9, 4.0) 1.25 (0.1, 3.5) <0.001 <0.001
Fluoroquinolones Enroﬂoxacin E. coli 17 0.06 (0.03,
0.25)
0.03 (0.02, 0.18) -0.03 (-0.11,
0.03)
0.001 <0.001
Salmonella
enterica
19 0.09 (0.06,
0.13)
0.05 (0.03, 0.13) -0.05 (-0.09,
0.03)
<0.001 <0.001
Classic macrolides Erythromycin E. coli 15 24.0 (12.0,
32.0)
256.0 (25.1,
256.0)
224.0 (13.1,
244.0)
<0.001 <0.001
Salmonella
enterica
19 24.0 (12.0,
45.1)
256.0 (31.2,
256.0)
232.0 (19.2,
243.3)
<0.001 <0.001
Azalides Azithromycin E. coli 15 2.0 (2.0, 4.0) 24.0 (12.0, 32.0) 22.0 (9.1, 30.0) <0.001 <0.001
Salmonella
enterica
19 2.0 (2.0, 4.0) 32.0 (16.0, 90.2) 28.0 (14.0, 86.4) <0.001 <0.001
Sulfonamides Sulfamethoxazole/
Trimethoprim
E. coli 15 0.05 (0.02,
0.75)
0.02 (0.01, 0.48) -0.04 (-0.52,
-0.01)
0.026 <0.001
Salmonella
enterica
18 0.50 (0.25,
0.75)
0.13 (0.03, 0.75) -0.32 (-0.65,
0.21)
<0.001 <0.001
Tetracyclines Tetracycline E. coli 11 2 (1, 3.8) 0.75 (0.4, 2.8) -0.9 (-1.3, 0.0) <0.001 <0.001
Salmonella
enterica
19 1.5 (1, 2) 0.8 (0.4, 1.0) -1.0 (-1.5, -0.1) <0.001 <0.001
doi:10.1371/journal.pone.0155599.t001
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BAP agar media, but the range of the difference varied between the media in some cases. For
example, the range of the difference was wider on BAP agar for E. coli susceptibility to enroflox-
acin (Fig 1 part V), but on MH agar for Salmonella enterica susceptibility to azithromycin (Fig
1 part VII). The two media differ in their composition, with BAP being a more complex agar
containing 5% sheep blood. Thus, the differences in the results between the two media sug-
gested a possibility that the change in bacterial antimicrobial susceptibility from aerobic to
anaerobic conditions may be affected further by the substrates available to support the bacterial
population growth.
A positive statistically significant correlation was observed between the relative magnitude
of the MIC values in aerobic and anaerobic conditions on MH agar for individual E. coli and
Salmonella enterica isolates for β-lactam antimicrobials (ampicillin, ceftriaxone), fluoroquino-
lone enrofloxacin, a classic macrolide erythromycin, and a sulfanomide sulfamethoxazole/tri-
methoprim (Table 2). That is, for these antimicrobial classes there was a tendency for the
relative magnitude of susceptibility of an isolate, compared to the other isolates, to remain con-
sistent between the two conditions (Table 2; Fig 1 parts I, II, V, VI, and VIII). No statistically
significant correlation was observed between the relative magnitude of the MIC values in aero-
bic and anaerobic conditions on MH agar for individual isolates for aminoglycoside gentami-
cin, azalide azithromycin, or tetracycline (Table 2; Fig 1 parts III, VII, and IX). That is, for
these antimicrobial classes the relative magnitude of susceptibility of an isolate, compared to
the other isolates, was not consistent between the two conditions. A similar pattern of the cor-
relations of the relative magnitude of the MIC values of individual isolates between the condi-
tions was observed on BAP agar. With the exception of susceptibility to azithromycin for
which a statistically significant positive correlation coefficient of 0.45 (p = 0.002) between the
Fig 1. Antimicrobial susceptibility of E. coli and Salmonella enterica isolates of diverse serovars in
aerobic and anaerobic conditions after a 24-hour adaptation to the conditions prior to the testing.
Box-plots of the differences in susceptibility of the isolates between aerobic and anaerobic conditions
(the p-value of the Wilcoxon signed rank test for each difference is included). Legend: I—Ampicillin. II—
Ceftriaxone. III—Gentamicin. IV–Kanamycin. V–Enrofloxacin. VI–Erythromycin. VII–Azithromycin. VIII–
Sulfamethoxazole/Trimethoprim. IX–Tetracycline. On the scatter plots, for each isolate, the solid black circle
is the MIC in aerobic test and the hollow blue circle is the MIC in anaerobic test. The isolates are sorted in the
order of increasing MIC values in aerobic conditions. For each bacterial species, the black lines denote the
distribution of the MIC values across the isolates in aerobic conditions: solid line– 1% quartile, long dash–
median, and short dash– 99% quartile. The magenda lines denote the distribution of the MIC values across
the isolates of that bacterial species in anaerobic conditions: solid line– 1% quartile, long dash–median, and
short dash– 99% quartile.
doi:10.1371/journal.pone.0155599.g001
Table 2. Correlations between the relative magnitude of the MIC values of individual isolates of E. coli and Salmonella enterica of diverse serovars
in aerobic and anaerobic conditions across the isolates tested (E-Test1 on Mueller-Hinton agar).
Antimicrobial drug class Representative drug
used
Isolates
tested, n
Spearman correlation coefﬁcient of MIC aerobic with
MIC anaerobic for individual isolates
p-
value
Older β-lactams aminopenicillins Ampicillin 34 0.65 <0.001
Newer β-lactams third generation
cephalosporins
Ceftriaxone 34 0.59 <0.001
Aminoglycosides Gentamicin 34 -0.30 0.085
Fluoroquinolones Enroﬂoxacin 36 0.59 <0.001
Classic macrolides Erythromycin 34 0.55 <0.001
Azalides Azithromycin 34 0.10 0.589
Sulfonamides Sulfamethoxazole/
Trimethoprim
33 0.85 <0.001
Tetracyclines Tetracycline 30 0.30 0.103
doi:10.1371/journal.pone.0155599.t002
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MIC values in aerobic and anaerobic conditions was observed on BAP agar. The correlation
for kanamycin was evaluated on BAP agar only, and was not statistically significant (correla-
tion coefficient of 0.28, p = 0.059); this was similar to the results for gentamicin on MH agar.
The ranges of the MIC values for the isolates analyzed are given in Table 1; the results of the
analysis of the correlations are given in Table 2.
In the satellite experiment, bacterial antimicrobial susceptibility in anaerobic conditions was
evaluated following from 0 to 48 hours of exposure to these conditions. The results of this
experiment suggested that adaptation of Gram-negative facultative anaerobic bacilli to anaero-
bic conditions is associated with dynamic changes in their antimicrobial susceptibility (Fig 2).
Distinct patterns of the dynamics of the changes were observed for individual antimicrobial
classes (Fig 2). Furthermore, although the overall direction of change in susceptibility (increase
or decrease compared to aerobic conditions) for a given antimicrobial was similar among indi-
vidual isolates of a given bacterial species, there was between-isolate variability in the dynamics
or magnitude of the changes with time in anaerobic conditions (Fig 2).
Discussion
The results of this study are consistent with the hypothesis that facultative anaerobe Gram-neg-
ative enteric bacteria can have different susceptibility to antimicrobials when exposed in aero-
bic vs. anaerobic conditions. Isolates of diverse serovars of E. coli (O26, O45, O103, O111,
O145), and Salmonella enterica (Agona, Anatum, Give, Infantis, Kentucky, Montevideo,
Muenchen, Oranienburg, Typhimurium) exhibited changes in their susceptibility to antimicro-
bial drugs (n30 isolates per drug) from aerobic to anaerobic conditions of the bacterial popu-
lation growth. Susceptibility to β-lactams, including aminopenicillins and third generation
cephalosporins, as well as to fluoroquinolones, sulfanomides, and tetracyclines increased sig-
nificantly. Susceptibility to aminoglycosides, classic macrolides, and azalides decreased signifi-
cantly. The isolates used had been obtained from cattle feces by earlier field studies in beef
feedlots. In our view, the observed differences in bacterial antimicrobial susceptibility between
the aeration conditions are likely independent of the isolate source. This premise, however, can
be tested in the future by investigating susceptibility of isolates from other sources (e.g. from
humans, monogastric animals, poultry or food products).
The observed differences in antimicrobial susceptibility from aerobic to anaerobic condi-
tions of facultative anaerobe Gram-negative enteric bacteria are likely associated with physio-
logical changes experienced by the bacteria. We conjuncture that the most influential may be
alterations in the bacterial population growth rate, respiration, or metabolism, as well as
changes in the uptake or activity of the antimicrobials due to the aeration conditions. This
observational study did not aim to distinguish the contributing processes. We conjecture that
the altered population growth rates likely affect the bacterial susceptibility to antimicrobial
drugs that inhibit synthesis of the cell wall of vegetative, growing-to-divide bacteria, such as β-
lactams. The altered metabolism can affect the susceptibility to antimicrobials that target major
metabolic cell functions, such as macrolides, sulfonamides, and tetracyclines. The differences
in activity of aminoglycosides in anaerobic conditions are better understood [20,28,29], and
are associated with a reduced aminoglycoside uptake by the bacteria due to changes in bacterial
respiration in anaerobic conditions [30].
This study was limited to E. coli and Salmonella enterica that were highly susceptible to anti-
microbial drugs tested (i.e., the isolates would be interpreted as susceptible to the drugs based
on the clinical breakpoint interpretation for human infection [7]). Such isolates were available
for the study in sufficient quantities to allow meaningful statistical analyses of the changes in
the bacterial susceptibility to the antimicrobials between aerobic and anaerobic conditions. By
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their virtue, the isolates had a range of relatively low MIC values for the antimicrobials
(Table 1). It is possible that the magnitude of the changes in susceptibility between the condi-
tions can differ for less susceptible isolates that manifest relatively high MIC values (i.e., isolates
that would be interpreted as intermediate or resistant to the antimicrobials based on the clinical
breakpoint interpretation), though the direction of the change can remain the same. Further,
the correlation between the relative magnitude of the susceptibility in aerobic and anaerobic
conditions may also differ for less susceptible isolates. Within the MIC value range of the sus-
ceptible isolates analyzed, there were positive and statistically significant correlations between
the relative magnitude of susceptibility of individual isolates in aerobic and anaerobic condi-
tions for β-lactams, fluoroquinolones, classic macrolides and sulfanomides, but not for amino-
glycosides, azalides or tetracyclines. It was not feasible to obtain a sufficiently large set of the
isolates with more diverse susceptibility levels (more variable MIC values for the antimicrobials
tested) at the time of this study.
At least one drug from each of the antimicrobial drug classes considered in this study is
labelled for use to treat cattle in the U.S. Pharmacodynamic models can be developed to
describe how the drugs or their active metabolites that reach the intestines of the treated ani-
mals affect the enteric bacterial populations and their antimicrobial resistance. The models
require measurements of the antimicrobial susceptibility of the bacteria in the conditions of the
exposure. The exposure likely occurs in the lower intestine where the conditions are anaerobic.
The results of this study demonstrate that susceptibility of Gram-negative facultative anaerobe
enteric bacteria, in particular important foodborne pathogens E. coli and Salmonella enterica,
changes in anaerobic conditions. Moreover, the change may depend on the time in anaerobic
conditions. Therefore, pharmacodynamic models aiming to evaluate the impact of antimicro-
bial use on antimicrobial resistance in enteric bacteria of the treated host should utilize mea-
surements of bacterial susceptibility that are obtained anaerobically and reflect the time
bacteria spend in anaerobic conditions of the host’s gastrointestinal tract prior to the antimi-
crobial exposure.
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Gentamicin. III–Kanamycin. IV–Enrofloxacin. V–Azithromycin.
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